<DOC>
	<DOCNO>NCT01241695</DOCNO>
	<brief_summary>The purpose study determine safety , acceptability efficacy 12-week intervention diabetes-specific oral nutritional supplement glycaemic control type 2 diabetic patient risk malnutrition</brief_summary>
	<brief_title>Safety , Acceptability Efficacy Long-term Intervention With Diabetes-specific Low-carbohydrate , High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement Glycaemic Control Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<criteria>diagnosis type 2 diabetes accord WHO diagnostic criterion 6 month : Fasting plasma glucose ( FPG ) ≥ 126 mg/dl ( 7.0 mmol/l ) 2h plasma glucose ≥ 200 mg/dl ( 11.1 mmol/l ) OGTT ( oral glucose tolerance test ) ; HbA1c 6.58.5 % ( confirm previous 3 month ) , capable use oral nutritional supplementation , stable control antidiabetic regime least 1 month , use metformin and/or sulphonylureas oral antidiabetic medication , need nutritional support ≥5 % involuntary weight loss last 3 month , ≥10 % involuntary weight loss last 6 month , inadequate nutritional intake cause failure meet nutritional requirement risk develop malnutrition diabetes type 1 , participation clinical trial investigational product regular use diseasespecific oral nutritional supplement within 4 week prior study start patient require fibre free diet , enteral tube fee parenteral nutrition , concomitant therapy systemic glucocorticoid , insulin antidiabetic medication metformin sulphonylureas , know suspected intolerance allergy component investigational product ( ) , acute gastrointestinal disease within 2 week prior study entry , gastrectomy , gastroparesis gastric empty abnormality , acute sever heart failure ( NYHA class 4 ) , liver insufficiency / failure ( male : ALAT &gt; 150 U/l ; female : ALAT &gt; 120 U/l ) renal failure require dialysis , cancer cachexia , galactosaemia , fructosaemia , suspicion drug abuse , abuse of/addiction alcohol , pregnant breast feed woman , fertile woman refuse use contraceptive , patient untreated major psychiatric disorder , know HIV positive ( safety reason ) , patient unable cooperate adequately</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Oral nutritional supplement , diabetes mellitus type 2 , glycaemic control</keyword>
	<keyword>Oral nutritional supplement ( Food special medical purpose )</keyword>
</DOC>